Humboldt Fund (Humboldt Ventures) is a venture capital fund that supports innovative, early-stage companies by investing in the biotech revolution. Synthetic biology is poised to transform the way we make chemicals, materials, foods and medicines. At Humboldt Fund, we identify and invest in pioneers of engineering, physical sciences and life sciences to bring emerging biotech enterprises to a global market. Together we explore, discover and create new technologies that disrupt global conventions and solve the critical issues of our world, while creating value and prosperity.
11
Total Investments
10
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Finance, Financial Services
Company Overview
About Humboldt Fund
Recent Investments (11)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Venture Round | •••••• | Jan 2023 | |
| Seed Round | •••••• | Dec 2022 | |
| Series A | •••••• | Jun 2022 | |
| Venture Round - Affini | •••••• | Mar 2022 | |
| Seed Round | •••••• | Feb 2022 | |
|
|
Seed Round | •••••• | Dec 2020 |
|
|
Series A | •••••• | Nov 2020 |
|
|
Series D | •••••• | Sep 2020 |
|
|
Pre Seed Round | •••••• | Aug 2020 |
|
|
Series A | •••••• | Aug 2019 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.